THOMPSON SIEGEL & WALMSLEY LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 110 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON SIEGEL & WALMSLEY LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q4 2017$40,000
-7.0%
3830.0%0.00%
-100.0%
Q3 2017$43,0000.0%3830.0%0.00%0.0%
Q2 2017$43,0003830.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q1 2018
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 650,089$27,95412.84%
Analyst IMS Investment Management Services Ltd. 13,557$5830.02%
LRI Investments, LLC 2,000$85,7780.01%
Gladius Capital Management LP 761$32,7010.00%
RHUMBLINE ADVISERS 12,625$542,4900.00%
Lindbrook Capital, LLC 142$6,1020.00%
Covestor Ltd 26$10.00%
Red Tortoise LLC 40$1,7190.00%
OSAIC HOLDINGS, INC. 199$8,5510.00%
Parallel Advisors, LLC 19$8160.00%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders